InBody Co.Ltd (041830) — Capital Reinvestment Ratio
InBody Co.Ltd (041830) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩9.04 Billion) in capital expenditures (₩3.64 Billion). Check 041830 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
InBody Co.Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks InBody Co.Ltd's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see InBody Co.Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for InBody Co.Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for InBody Co.Ltd from 2011 to 2024. See 041830 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | ₩28.58 Billion | ₩7.55 Billion | ▲ +33.8% |
| 2023 | 0.20x | ₩38.69 Billion | ₩7.64 Billion | ▼ -0.1% |
| 2022 | 0.20x | ₩30.42 Billion | ₩6.02 Billion | ▼ -47.6% |
| 2021 | 0.38x | ₩30.35 Billion | ₩11.45 Billion | ▲ +537.4% |
| 2020 | 0.06x | ₩28.50 Billion | ₩1.69 Billion | ▼ -53.4% |
| 2019 | 0.13x | ₩24.21 Billion | ₩3.08 Billion | ▼ -94.5% |
| 2018 | 2.31x | ₩17.70 Billion | ₩40.86 Billion | ▲ +707.1% |
| 2017 | 0.29x | ₩18.58 Billion | ₩5.31 Billion | ▼ -37.9% |
| 2016 | 0.46x | ₩18.24 Billion | ₩8.41 Billion | ▼ -31.8% |
| 2015 | 0.68x | ₩11.18 Billion | ₩7.55 Billion | ▲ +372.3% |
| 2014 | 0.14x | ₩10.26 Billion | ₩1.47 Billion | ▼ -89.2% |
| 2013 | 1.32x | ₩6.99 Billion | ₩9.26 Billion | ▲ +609.8% |
| 2012 | 0.19x | ₩4.36 Billion | ₩812.05 Million | ▼ -57.4% |
| 2011 | 0.44x | ₩5.50 Billion | ₩2.41 Billion | — |